The global Preterm Birth And Prom Testing Market is estimated to be valued at US$ 1.69 Bn in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
The preterm birth and prom testing market deals with tests and assays that help in determining the risk of premature birth through the analysis of various biochemical markers found in maternal blood, urine or vaginal secretions. These tests assess fetal fibronectin levels, cervical length, fetal fibrillin levels and more to assess the risk of preterm birth. Advances in cell culture techniques have expanded options for assessing genetic and molecular factors through fetal cell cultures grown from amniotic fluid samples.
Market Key Trends:
One of the key trends in the preterm birth and prom testing market is the increasing use of fetal fibroblast cell culture. Fetal cells grown in cell culture provide biomaterial that can be used for various molecular and genetic analyses to gain insights about fetal health and development. Since these cells carry the genome of the fetus, they offer a lens into causes of preterm labor at the genetic and molecular level. Advances in cell culture protocols have made it possible to culture fetal fibroblast cells from amniotic fluid samples in a reliable manner. This is fueling the adoption of cell culture-based tests for advanced preterm birth risk assessment.
Segment Analysis
The global preterm birth and prom testing market is segmented into product, method, application, and end user. Based on product, the market is segmented into consumables and equipment. The consumables segment is dominating the preterm birth and prom testing market as it requires recurrent procurement of consumables such as assay kits, reagents, and others. Based on method, the market is segmented into biomarker testing, fetal fibronectin test (fFN), ultrasound, and others. The biomarker testing segment is dominating the market as it allows recognizing those at higher risk of preterm delivery by analyzing a number of different proteins and metabolites in various body fluids.
Key Takeaways
Global Preterm Birth And Prom Testing Market Demand is expected to witness high growth, exhibiting a CAGR of 12% over the forecast period, due to increasing incidences of preterm births globally.
Regional analysis: North America is expected to dominate the global preterm birth and prom testing market over the forecast period. The dominance is attributed to the increasing number of preterm births and growing awareness regarding preterm birth testing in the region.
Key players operating in the preterm birth and prom testing market are Abbott Laboratories, Biosynex, Qiagen Sciences LLC, Clinical Innovations LLC, Sera Prognostics, The Cooper Companies Inc., Medixbiochemica, Hologic Inc., IQ Products, NX Prenatal Inc., Promega Corporation, Medical Predictive Technologies Inc., Biosynex, Clinical Innovations LLC, NX Prenatal Inc., Medixbiochemica, Qiagen Sciences LLC, Sera Prognostics Inc., Insight Pharmaceuticals LLC, Creative Diagnostics. Abbott Laboratories is dominating the market with its extensive product portfolio for preterm birth and prom testing.
Read More- https://www.marketwebjournal.com/preterm-birth-and-prom-testing-market-size-share-and-demand/
The Preterm Birth And PROM Testing Market research report provides the latest industry data, growth, key segments and future trends on the basis of the detailed study.
This market report also allows you to identify the future opportunity and growth rate of the leading segment based on regions and countriesThe research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the preterm birth and PROM testing market include Abbott Laboratories, Biosynex, Clinical Innovations, LLC, Cooper Companies, Inc., Hologic, Inc., IQ Products, Medix Biochemica, NX Prenatal, Inc., QIAGEN, and Sera Prognostics, Inc.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Preterm Birth And PROM Testing Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/preterm-birth-and-prom-testing-market/download-sampleMarket DynamicsThe increasing number of preterm births due to the rising average number of women being pregnant is primarily driving the market growth.
The rising various health issues such as diabetes and high blood pressure among women is also fuelling the demand for preterm birth and PROM testing.
However, the availability of alternative diagnostic options such as ultrasound, transvaginal scan, uterine monitoring, and lab tests are likely to hamper the market growth.
Transparency Market Research (TMR) has published a new report titled, “Preterm Birth and PROM Testing - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.
Increase in number of preterm births, growth of the medical diagnostics industry in emerging economies in regions such as Asia Pacific, and adoption of latest technologies and techniques to access or diagnose preterm births are projected to augment the global market between 2018 and 2026.Request Brochure –https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=55416Increase in Preterm Births to Propel MarketSedentary lifestyle along with several other factors has led to increase in preterm births, which has become a major concern in the past few years.
Point-of-care testing devices have also assisted in reducing the chances of complications due to preterm births by enabling diagnosis at early stages and allowing health care providers to offer immediate care to mother and fetus at early stages of pregnancy.Request COVID Analysis on Preterm Birth and PROM Testing Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=55416Lack of Awareness about Preterm Births to Restrain MarketLack of awareness about preterm births and PROM could lead to longer hospital stays and preventable expenditure from the perspective of patients.
Additionally, lack of awareness about availability of latest technologies available for diagnosis of premature births, resulting in delayed diagnosis and treatment is one of the major factors hampering the growth of the market.Request Customization on Preterm Birth and PROM Testing Market Report –https://www.transparencymarketresearch.com/sample/sample.php?flag=CR_id=55416Asia Pacific Market to Grow at a Rapid PaceIn terms of revenue, the preterm birth and PROM testing market in Asia Pacific is projected to expand at a high CAGR during the forecast period.
Furthermore, surge in awareness about women’s health and increase in expenditure on health care in the region are anticipated to present lucrative opportunities in the market in the next few years.Buy Preterm Birth and PROM Testing Market Report –https://www.transparencymarketresearch.com/checkout.php?rep_id=55416=SCollaborative Efforts by Key Players to Boost MarketThe report also provides profiles of leading players operating in the global preterm and PROM testing market.
These include NX Prenatal, Inc., IQ Products, QIAGEN, Hologic, Inc., The Cooper Companies, Inc., Medix Biochemica, Abbott Laboratories, Clinical Innovations, LLC, Sera Prognostics, Inc., and Biosynex.
